tm logo
FLEXIBZUMAB
REGISTERED

on 30 Sep 2024

Last Applicant/ Owned by

ELASTRIN THERAPEUTICS INC.

200C Patewood Drive,Room 4148Greenville SC 29615

US

Serial Number

2167164 filed on 09th Dec 2021

Registration Number

TMA1259402 registered on 30th Sep 2024

Registration expiry Date

09th Dec 2031

Correspondent Address

1939 Boul De Maisonneuve OMontréal

QUEBEC

CA

H3H1K3

FLEXIBZUMAB

Trademark usage description

pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as a drug delivery system for guiding therapeutic agents to a tar Read More

Classification Information


Class [005]
Pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as a drug delivery system for guiding therapeutic agents to a target tissue for the treatment of cardiovascular diseases, high blood pressure, arteriosclerosis, aneurysms, diabetes, kidney diseases, and chronic obstructive pulmonary disease (COPD); therapeutic pharmaceutical for the treatment of cardiovascular diseases, high blood pressure, arteriosclerosis, aneurysms, diabetes, kidney diseases, and chronic obstructive pulmonary disease (COPD); pharmaceutical antibody preparations for therapeutic purposes, namely, for the treatment of cardiovascular diseases, high blood pressure, arteriosclerosis, aneurysms, diabetes, kidney diseases, and chronic obstructive pulmonary disease (COPD); pharmaceutical antibodies for use as carriers for targeting drugs to calcified tissue for the treatment of cardiovascular diseases, high blood pressure, arteriosclerosis, aneurysms, diabetes, kidney diseases, and chronic obstructive pulmonary disease (COPD).


Classification kind code

11

Mark Details


Serial Number

2167164

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 31st May 2023
Search Recorded
Submitted for opposition 20
on 31st May 2023
Examiner's First Report
Submitted for opposition 223
on 31st May 2023
Total Provisional Refusal
Submitted for opposition 135
on 09th Mar 2023
Amendment to Application
Submitted for opposition 256
on 19th Dec 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 17th Feb 2022
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 17th Feb 2022
Formalized
Submitted for opposition 1
on 17th Feb 2022
Created
Submitted for opposition 228
on 09th Dec 2021
International Registration
Submitted for opposition 30
on 09th Dec 2021
Filed